729 related articles for article (PubMed ID: 24583405)
1. Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice.
Moon M; Cha MY; Mook-Jung I
J Alzheimers Dis; 2014; 41(1):233-41. PubMed ID: 24583405
[TBL] [Abstract][Full Text] [Related]
2. MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.
Jeong YO; Shin SJ; Park JY; Ku BK; Song JS; Kim JJ; Jeon SG; Lee SM; Moon M
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29912176
[TBL] [Abstract][Full Text] [Related]
3. MK0677, a Ghrelin Mimetic, Improves Neurogenesis but Fails to Prevent Hippocampal Lesions in a Mouse Model of Alzheimer's Disease Pathology.
Tian J; Wang T; Wang Q; Guo L; Du H
J Alzheimers Dis; 2019; 72(2):467-478. PubMed ID: 31594237
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.
Sanchez-Ramos J; Song S; Sava V; Catlow B; Lin X; Mori T; Cao C; Arendash GW
Neuroscience; 2009 Sep; 163(1):55-72. PubMed ID: 19500657
[TBL] [Abstract][Full Text] [Related]
5. Allopregnanolone enhances the neurogenesis of midbrain dopaminergic neurons in APPswe/PSEN1 mice.
Zhang P; Xie MQ; Ding YQ; Liao M; Qi SS; Chen SX; Gu QQ; Zhou P; Sun CY
Neuroscience; 2015 Apr; 290():214-26. PubMed ID: 25637494
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin prevents β-amyloid(25-35)-impaired neurogenesis in hippocampal dentate gyrus through α7nAChR-dependent cascading PI3K-Akt and increasing BDNF via reduction of farnesyl pyrophosphate.
Wang C; Chen T; Li G; Zhou L; Sha S; Chen L
Neuropharmacology; 2015 Oct; 97():122-32. PubMed ID: 26051402
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.
Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L
Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311
[TBL] [Abstract][Full Text] [Related]
8. Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease.
Zhang C; McNeil E; Dressler L; Siman R
Exp Neurol; 2007 Mar; 204(1):77-87. PubMed ID: 17070803
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.
Blanchard J; Wanka L; Tung YC; Cárdenas-Aguayo Mdel C; LaFerla FM; Iqbal K; Grundke-Iqbal I
Acta Neuropathol; 2010 Nov; 120(5):605-21. PubMed ID: 20697724
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
Fragkouli A; Tsilibary EC; Tzinia AK
Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
[TBL] [Abstract][Full Text] [Related]
11. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L
J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581
[TBL] [Abstract][Full Text] [Related]
12. Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease.
Girard SD; Jacquet M; Baranger K; Migliorati M; Escoffier G; Bernard A; Khrestchatisky M; Féron F; Rivera S; Roman FS; Marchetti E
Hippocampus; 2014 Jul; 24(7):762-72. PubMed ID: 24596271
[TBL] [Abstract][Full Text] [Related]
13. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
14. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
[TBL] [Abstract][Full Text] [Related]
15. Intrahippocampal injection of Aβ1-42 inhibits neurogenesis and down-regulates IFN-γ and NF-κB expression in hippocampus of adult mouse brain.
Zheng M; Liu J; Ruan Z; Tian S; Ma Y; Zhu J; Li G
Amyloid; 2013 Mar; 20(1):13-20. PubMed ID: 23286786
[TBL] [Abstract][Full Text] [Related]
16. Icariin decreases both APP and Aβ levels and increases neurogenesis in the brain of Tg2576 mice.
Li F; Dong HX; Gong QH; Wu Q; Jin F; Shi JS
Neuroscience; 2015 Sep; 304():29-35. PubMed ID: 26079110
[TBL] [Abstract][Full Text] [Related]
17. Early Impairments of Hippocampal Neurogenesis in 5xFAD Mouse Model of Alzheimer's Disease Are Associated with Altered Expression of SOXB Transcription Factors.
Zaletel I; Schwirtlich M; Perović M; Jovanović M; Stevanović M; Kanazir S; Puškaš N
J Alzheimers Dis; 2018; 65(3):963-976. PubMed ID: 30103323
[TBL] [Abstract][Full Text] [Related]
18. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease.
Hamilton A; Holscher C
Brain Res; 2012 Apr; 1449():83-93. PubMed ID: 22418058
[TBL] [Abstract][Full Text] [Related]
19. Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model.
Yu Y; He J; Zhang Y; Luo H; Zhu S; Yang Y; Zhao T; Wu J; Huang Y; Kong J; Tan Q; Li XM
Hippocampus; 2009 Dec; 19(12):1247-53. PubMed ID: 19309037
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer's disease.
Maiti P; Paladugu L; Dunbar GL
BMC Neurosci; 2018 Feb; 19(1):7. PubMed ID: 29471781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
